Fiche centre
Purpan Hospital
Toulouse — France
Essais liés2clinical trials
VilleToulouselocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT02403947
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Two-dose M0-M2 vaccination schedule | SEP | Phase 4 | NCT07818356 | TACTIC — Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial | NOT_YET_RECRUITING |
| Mesenchymal stem cells | SEP | Phase 1/2 | NCT02403947 | MESEMS — MEsenchymal StEm Cells for Multiple Sclerosis | TERMINATED |